Gene therapy progress and prospects: therapeutic angiogenesis for limb and myocardial ischemia
- 1 February 2003
- journal article
- review article
- Published by Springer Nature in Gene Therapy
- Vol. 10 (4) , 285-291
- https://doi.org/10.1038/sj.gt.3301969
Abstract
After extensive investigation in preclinical studies and recent clinical trials, gene therapy has been established as a potential method to induce therapeutic angiogenesis in ischemic myocardial and limb disease. Advancements in viral and nonviral vector technology including cell-based gene transfer will continue to improve transgene transmission and expression efficiency. An alternative strategy to the use of transgenes encoding angiogenic growth factors is therapy based on transcription factors such as hypoxia-inducible factor-1alpha (HIF-1alpha) that regulate the expression of multiple angiogenic genes. Further understanding of the underlying biology of neovascularization is needed to determine the ability of growth factors to induce functionally significant angiogenesis in patients with atherosclerotic disease and associated comorbid conditions including endothelial dysfunction, which may inhibit blood vessel growth. The safety and tolerability of therapeutic angiogenesis by gene transfer has been demonstrated in phase I clinical trials. However, limited evidence of efficacy resulted from early phase II studies of angiogenic gene therapy for ischemic myocardial and limb disease. The utility of therapeutic angiogenesis by gene transfer as a treatment option for ischemic cardiovascular disease will be determined by adequately powered, randomized, placebo-controlled phase II and III clinical trials.Keywords
This publication has 39 references indexed in Scilit:
- Effects of intramyocardial injection of phVEGF‐A165 as sole therapy in patients with refractory coronary artery disease – 12‐month follow‐up: Angiogenic gene therapyJournal of Internal Medicine, 2001
- Gene transfer to induce angiogenesis in myocardial and limb ischaemiaExpert Opinion on Biological Therapy, 2001
- Efficient Expression of the Vascular Endothelial Growth Factor Gene In Vitro and In Vivo, Using an Adeno-associated Virus VectorJournal of Molecular and Cellular Cardiology, 2001
- Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial diseaseGene Therapy, 2001
- Gene Transfer for Angiogenesis in Coronary Artery DiseaseAnnual Review of Medicine, 2001
- Efficient in vivo gene transfer by PCR amplified fragment with reduced inflammatory activityGene Therapy, 2001
- Microbubble-enhanced ultrasound for vascular gene deliveryGene Therapy, 2000
- Liposome-mediated, nonviral gene transfer induces a systemic inflammatory response which can exacerbate pre-existing inflammationGene Therapy, 2000
- Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, etsGene Therapy, 2000
- Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121 1 1Ronald G. Crystal and Todd K. Rosengart contributed equally as senior investigators in this study.The Annals of Thoracic Surgery, 2000